These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6421223)

  • 1. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
    Lagarde M; Bordet JC; Croset M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotension induced by molsidomine or trinitroglycerin].
    Dassier P; Blanloeil Y; Pinaud M; Bodin D; Vandeville B
    Cah Anesthesiol; 1985; 33(4):309-13. PubMed ID: 3931864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
    Basista M; Grodzińska L; Swies J
    Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological effects of SIN-1 in the vascular wall].
    Astoin M; Canton-Poincelot B; Masson A; Russo-Marie F
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):244-6. PubMed ID: 3104867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of molsidomine and nitroglycerin on the regional blood flow in the normal and acutely ischemic myocardium (author's transl)].
    Scholtholt J; Fiedler VB; Keil M
    Arzneimittelforschung; 1978; 28(9):1619-24. PubMed ID: 113017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of molsidomine, an anti-anginal drug, on arachidonic acid metabolism in human platelets.
    Croset M; Lagarde M
    Biomed Biochim Acta; 1984; 43(8-9):S354-7. PubMed ID: 6440549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium taurocholate affects prostacyclin constitutive production by cultured human vascular endothelial cells.
    Calcamuggi G; Lanzio M; Babini G; Martini S; Anfossi G; Emanuelli G
    J Lab Clin Med; 1990 Jun; 115(6):756-60. PubMed ID: 2114471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of nitroglycerin and molsidomine. Effects on the integrated systemic venous bed and the arterial pressure in dogs.
    Grund E; Müller-Ruchholtz ER; Lapp ER; Lösch HM; Lochner W
    Arzneimittelforschung; 1978; 28(9):1624-8. PubMed ID: 113018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasorelaxing actions of molsidomine and its metabolites, in comparison with nitroglycerin.
    Muramatsu I; Fujii K; Sakakibara Y; Fujiwara M
    Can J Physiol Pharmacol; 1983 Sep; 61(9):1071-8. PubMed ID: 6416660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
    Bordet JC; Lagarde M
    Biochem Pharmacol; 1988 Oct; 37(20):3911-4. PubMed ID: 3142481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of nitroglycerin and nitroprusside on prostacyclin generation in adult human vessel wall.
    Mehta J; Mehta P; Roberts A; Faro R; Ostrowski N; Brigmon L
    J Am Coll Cardiol; 1983 Oct; 2(4):625-30. PubMed ID: 6411788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of vasodilation by molsidomine.
    Kukovetz WR; Holzmann S
    Am Heart J; 1985 Mar; 109(3 Pt 2):637-40. PubMed ID: 2983523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.